RBC Capital Maintains Outperform on Exelixis, Raises Price Target to $34

Benzinga · 10/16 12:27
RBC Capital analyst Gregory Renza maintains Exelixis (NASDAQ:EXEL) with a Outperform and raises the price target from $30 to $34.